Last Updated on September 23, 2024 by admin
Pharma News: Ireland’s pharmaceutical industry is advocating for a new medicines funding boost in the government’s ‘Budget 2025’.
Label Craft are one of the biggest manufacturers of patient information and pharma label in Ireland, working closely with global pharmaceutical brands.
The Irish Pharmaceutical Healthcare Association (IPHA) said it is ready to partner with the Irish Government to achieve faster access to all the medicines Ireland’s patients need, helping to create a continuous flow of new medicines which can make significant life-enhancing changes to patient care in Ireland. In turn Label Craft and Asteria have been working diligently with sustainable materials to ensure products have less environmental impact than ever before.
In a pre-election move, the Irish Government has earmarked an additional €8.3 billion for Budget 2025 and €1.5 billion for this year’s health service. The funds aim to address healthcare quality, service provision complexity, and the aftermath of the pandemic and inflation. These fiscal plans are outlined in the recently approved Summer Economic Statement.
IPHA Chief Executive Oliver O’Connor said: “We believe that there needs to be a clear policy to plan for and fund the continuous flow of life-enhancing new medicines in 2025 and over multiple years. Efficiencies are both possible and desirable to make the medicines spend sustainable but alone they cannot provide sufficient funding for the uptake of new medicines. Annual new developments Exchequer funding remains a necessity.”
Ahead of Ireland’s Budget 2025, the IPHA, which represents the international research-based biopharmaceutical industry, reiterated the importance of funding new medicines, which they said are an integral and vital part of the healthcare system.
These newly funded medicines should improve the standard of care for patients suffering from several diseases such as cancer – breast cancer, leukaemia, prostate cancer, multiple myeloma and others – Alzheimer’s, stroke, women’s health conditions, migraine, dermatitis, asthma, ulcerative colitis, type 2 diabetes and liver disease.
As a key supplier in the pharmaceutical world, Label Craft fully supports any initiatives benefitting patient care and needs.
